Historical salary details - Mr. David D. Meek, Director, Cullinan Oncology Inc
Mr. David D. Meek is the Director of Cullinan Oncology Inc. They also hold 1 other positions in and uniQure N.V..
Mr. David D. Meek
Director
-
Gross Remuneration
-
Current Company
Cullinan Oncology Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Cullinan Oncology Inc | Director | - | - |
| 2024 | uniQure N.V. | Chairman of the Board | - | - |
| 2023 | uniQure N.V. | Chairman of the Board | 445.0 K | 13.9 % |
| 2023 | Fusion Pharmaceuticals Inc | Director | - | - |
| 2023 | Mirati Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2023 | Cullinan Oncology Inc | Independent Director | - | - |
| 2022 | uniQure N.V. | Chairman of the Board | 390.7 K | 66.5 % |
| 2022 | Mirati Therapeutics Inc | Chief Executive Officer and Director | - | - |
| 2021 | uniQure N.V. | Chairman of the Board | 234.7 K | -20.9 % |
| 2020 | uniQure N.V. | Independent Director | 296.8 K | 2.3 % |
| 2019 | uniQure N.V. | Independent Director | 290.1 K | 409.0 % |
| 2018 | uniQure N.V. | Independent Director | 57.0 K | - |
| 2017 | uniQure N.V. | Director | - | - |